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Abstract
Purpose: To monitor changes in habits in drug use among Italian high school students.
Methods: Cross-sectional European School Survey Project on Alcohol and Other Drugs (ESPAD) carried out in Italy annually
for 11 years (1999–2009) with representative samples of youth attending high school. The sample size considered ranges
from 15,752 to 41,365 students and response rate ranged from 85.5% to 98.6%. Data were analyzed to obtain measures of
life-time prevalence (LT), use in the last year (LY), use in the last 30 days (LM), frequent use. Comparisons utilized difference
in proportion tests. Tests for linear trends in proportion were performed using the Royston p trend test.
Results: When the time-averaged value was considered, cannabis (30% LT) was the most, and heroin the least (2%)
frequently used, with cocaine (5%), hallucinogens (2%) and stimulants (2%) in between. A clear gender gap is evident for all
drugs, more obvious for hallucinogens (average M/F LY prevalence ratio 2, range 1.7–2.4, p,0.05), less for cannabis (average
M/F LY prevalence ratio 1.3, range 1.2–1.5, p,0.05). Data shows a change in trend between 2005 and 2008; in 2006 the
trend for cannabis use and availability dropped and the price rose, while from 2005 cocaine and stimulant use prevalence
showed a substantial increase and the price went down. After 2008 use of all substances seems to have decreased.
Conclusions: Drug use is widespread among students in Italy, with cannabis being the most and heroin the least prevalent.
Girls are less vulnerable than boys to illegal drug use. In recent years, a decrease in heroin use is overbalanced by a marked
rise in hallucinogen and stimulant use.
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Introduction
In most industrialized countries the use of illegal psychoactive
substances is a serious public health challenge, and usually begins
during adolescence [1]. Thus, in all countries it is a public health
imperative to assess the population rates of illicit drug use among
adolescents. In addition, monitoring trends over time may reflect
the net effects of activities and programs carried out to prevent
adolescent substance use.
The European School Survey Project on Alcohol andOther Drugs
(ESPAD) collects comparable data on substance use among Euro-
pean students in order to monitor trends within as well as between
countries [2]. One of the most important and useful results from the
ongoing series of ESPAD surveys is the estimation of changes taking
place in the school population— changes in use of various drugs, in
attitudes and beliefs that may help to explain changes in use, and
within various demographic subgroups in the study population. The
ESPAD study is also useful for assessing which new drugs or sub-
stances may be gaining favor, and in which subgroups or areas. This
information has important implications for public policy—for assess-
ing needs, setting agendas, and formulating and evaluating policies.
More generally, it has implications for the health of the nation [3].
In our Institute, we carried out the Italian branch of the cross-
sectional ESPAD study every year for 11 consecutive years (1999–
2009) in representative samples of Italian youth attending school,
yielding a continuous record of trends in drug use. Data collection
was performed by standardized methodology using anonymous
self-administered questionnaires completed in the classroom.
Based on 11 consecutive years of a national school survey in
Italy, this study aimed to examine the trend of cumulative and
onset use of illegal drugs among school-age adolescents and the
relationship between various measures of prevalence of illicit drug
use and the perception of accessibility, prices of the illegal
substances and changes in the drug laws and policies.
Methods
Procedure and participants
Data reported in this study are part of an ongoing longitudinal
survey study by the Institute of Clinical Physiology of the Italian
National Research Council. For this study, we used the data
regarding eleven consecutive years, from ESPAD-ItaliaH1999 to
ESPAD-ItaliaH2009 and prevalence of drug use was measured by
identical instruments and methodology every year. The survey
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takes place every year in March–April; the survey assessments
were self-administered using paper and pencil, requiring a
duration of 40 minutes to complete. From 1999 a representative
Italian student sample, aged 15–19 years, have been questioned
about psychoactive substance use as well as leisure activities,
relationships at school, attitude concerning drug use (approval or
perceived risk), satisfaction with relationships with parents or
friends, social and cultural status. General information about the
sample, data collection and questionnaire is described in detail in
Hibell et al. [2].
Repeating these cross-sectional studies over time allows an
assessment of change across years in those same segments of the
student population. Sample characteristics are reported in Table 1.
Measures
Drug use can be measured in terms of prevalence (the
proportion of a defined population who have used a drug once
or more in a particular time interval) or in terms of frequency (how
many times they used the drug within a defined time interval). In
this paragraph, both these important aspects of drug use are
addressed in relation to each of the three time intervals considered
in the ESPAD study — lifetime (LT), past 12 months (LY), past 30
days (LM), current frequent use (F) — utilizing data from the most
recently completed cross-sectional surveys from high-school
students, conducted in the spring. We also examine how
prevalence of use varies across gender groups.
To analyze drug use among adolescents, information about
lifetime, last year, and last month use variables were recorded by
the answer to the questions ‘‘On how many occasions (if any) have
you used …?’’ in the lifetime, last year and last month, with
response categories: ‘‘never, once or twice, 3–5 times, 6–9 times,
10–19 times, 20–39 times and 40 times or more’’.
In agreement with the item analyzed in Monitoring The Future
Research [4], respondents were considered current frequent users
if they indicated that they had used the drug on 20 or more
occasions in the previous 30 days.
Data regarding lifetime use were collected from 1999 only for
cannabis (marijuana or hashish), cocaine (also powder) and heroin
(smoked and not), and from 2003 for hallucinogens (LSD and
mushroom) and stimulants (GHB, ecstasy and amphetamines).
Data regarding use in the last year were collected from 1999
only for cannabis, from 2000 for cocaine and heroin, and from
2003 for hallucinogens and stimulants.
Data regarding use in the last month and frequent use were
collected from 1999 only for cannabis, from 2002 for cocaine and
heroin, and from 2003 for hallucinogens and stimulants.
One set of questions asks respondents how difficult they think it
would be to obtain each of a number of different drugs if they
wanted it. Perceived availability was dichotomized as very easy
and fairly easy (coded as 1) vs other responses (fairly difficult; very
difficult; impossible; don’t know) [5].
Data on street costs of drugs were officially supplied by the
Italian Interior Ministry [6].
Statistical analysis
Prevalence with 95% confidence interval, for lifetime, last year,
last month and frequent drug use were computed using Stata,
version 10 for Windows (Stata Corp, 2001). Chi-square analyses
were used to test these prevalences for gender differences.
Statistical significance was set at p,0.05 (two-tailed). Tests for
linear trend in proportion were performed using the Royston p
trend test in the Stata module for trend analysis. Prevalence last
year and last month use (except for frequent cannabis use) were
also compared to determine whether the changes in prevalence of
substance were related for change in perceived availability or in
price. Short-term trends of each line segment were denoted by the
percent change from first data available (i.e. for LY cannabis use
the referent year is 1999, instead for cannabis street price 2001).
Results
Prevalence of drug use is reported in Tables 2 and 3 for boys
and girls respectively. For each year and gender, data are provided
separately for each of the five major classes of illicit drugs. When
the time-averaged value is considered, cannabis (over 30% of
lifetime use) is the most, and heroin the least (LT use less than 3%)
used, with cocaine (5%), hallucinogens and stimulants (4%) in
between. A clear gender gap is evident for all drugs, more obvious
for hallucinogens (average M/F LY prevalence ratio 2, range 1.7–
2.4, p,0.05), stimulant (average M/F LY prevalence ratio 1.8,
range 1.5–2.2, p,0.05) and cocaine (average M/F LY prevalence
ratio 1.7, range 1.3–2.3, p,0.05) less for heroin (average M/F LY
prevalence ratio 1.4, range 1.1–1.8, p,0.05) and cannabis
(average M/F LY prevalence ratio 1.3 range 1.2–1.5, p,0.05).
Over the years, LY cannabis use steady dropped (p,0.001) (Fig. 1),
LY use of cocaine (Fig. 2) remained more or less stable, and LY
heroin use(Fig. 3) decreased as well (p,0.001); whereas LY
hallucinogen use (Fig. 4) and, more markedly, LY stimulant use
(Fig. 5) increased (p,0.001). Regarding availability, cannabis has
been the most consistently available illicit drug, but even it showed
a small decrease over the years (Fig. 1), the same trend shown by
hallucinogens and stimulants. Cocaine availability shows an
increasing trend from 2006; 1 student in 5 reported easy
accessibility of the drug. In the case of heroin availability, the
situation is more stable.
Discussion
Our study shows that illicit drug use is a widespread and
probably expanding epidemic among Italian high school students,
with cannabis still at least five times more prevalent than any other
drug. Boys are more vulnerable than girls to drug use. Drug
Table 1. Samples characteristics.
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
N 20185 22418 22257 15752 25299 32372 41365 38748 40407 38681 32461
Age (mean) 17.261.6 17.161.5 17.161.4 17.261.6 17.161.6 17.161.6 17.161.6 17.161.6 17.161.6 17.261.6 17.161.6
Gender (male) 41,8% 47,3% 45,0% 45,5% 45,5% 48,1% 48,1% 48,9% 49,7% 49,0% 49,2%
Response rate* 94,3% 92,2% 87,1% 98,6% 94,9% 96,1% 94,1% 88,9% 92,4% 85,8% 89,2%
*Response rate of schools participating in the survey.
doi:10.1371/journal.pone.0020482.t001
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Figure 1. Cannabis. Percentage differences in LY and frequent cannabis use prevalence, in perceived cannabis availability prevalence and
percentage differences in street price of cannabis.
doi:10.1371/journal.pone.0020482.g001
Figure 2. Cocaine. Percentage differences in LY and LM cocaine use prevalence, in perceived cocaine availability prevalence and percentage
differences in street price of cocaine.
doi:10.1371/journal.pone.0020482.g002
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Figure 3. Heroin. Percentage differences in LY and LM heroin use prevalence, in perceived heroin availability prevalence and percentage
differences in street price of heroin.
doi:10.1371/journal.pone.0020482.g003
Figure 4. Hallucinogens. Percentage differences in LY and LM hallucinogen use prevalence, in perceived hallucinogen availability prevalence and
percentage differences in street price of hallucinogens.
doi:10.1371/journal.pone.0020482.g004
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consumption also shows a dynamic evolution over time, possibly
modulated by cultural, political and economic factors, such as
changing laws and variability of market prices. In spite of
conspicuous legislative and social communication efforts in the
field by various governments in the last 10 years, the prevalence of
drug use was remarkably stable for the most commonly used drugs
such as cannabis and cocaine, with a decrease in heroin
overbalanced by a marked rise in hallucinogen and stimulant
use. Data shows a change in trend between 2005 and 2008; in
2006 the trend for cannabis use and availability dropped and its
price rose (Fig. 1), while from 2005 cocaine and stimulant use
prevalence showed a substantial increase and the price went down
(Figs. 2 and 4). After 2008 the use of all substances seems to have
decreased.
Study relevance
The findings of this study have social, medical and possibly
legislative implications. The long-term adverse health consequenc-
es of illicit drug use are well documented, but short-term outcomes
among adolescents are also important and include association with
injury, violence and suicide, teenage pregnancy, sexually trans-
mitted diseases, and poor mental health [7]. There is increasing
concern about drug use during adolescence, since brain develop-
ment during this period is more vulnerable to drug-related deficits
[8]. At the public health level, the large proportion of adolescents
who misuse psychoactive substances calls for more effective
intervention strategies as well as better perception by politicians
and decision makers of the seriousness and complexity of this issue
[1,9,10,11,12].. The legislative climate in Italy has recently
changed, with more stringent control of illegal drug use. The
current 2006 law (L 49/2006) modified the previous one of 1990
(DPR 309/1990). The new regulatory framework was character-
ized by stiffer penalties in relation to the production, trafficking,
possession and use of drugs, and by the abolition of any distinction
between different kind of illicit drugs. Two hypotheses have been
advanced to explain this mismatch between increased awareness of
the problem by policy-makers, conspicuous legislative and
communication efforts and lack of commensurate results. First,
many preventive programs, especially in the school setting, are run
as one-shot interventions, without a long-term link to parents and
the surrounding community. Successful projects in the field tend to
emphasize life skills and the participation of young people and
parents/communities [13]. Second, social communication and
legislative measures can see their effects minimized and even
nullified by the phenomenon of cognitive dissonance [14]. If not
recognized and properly handled, the emotional state of
dissonance – which occurs when there is inconsistency between
two cognitions or between a cognition and a behavior - is a strong
barrier to changing behaviors in several health-related situations,
including substance abuse and prevention of addiction, recently
shown for instance in effective attempts to reduce adolescents’
overuse of online gaming [15].
Comparison with previous studies
Our data are in agreement with previous studies showing the
large prevalence of adolescent drug use in Europe [11,16–20] with
Figure 5. Stimulants. Percentage differences in LY and LM stimulant use prevalence, in perceived stimulant availability prevalence and percentage
differences in street price of stimulants.
doi:10.1371/journal.pone.0020482.g005
Changes in Drug Use
PLoS ONE | www.plosone.org 7 June 2011 | Volume 6 | Issue 6 | e20482
greater vulnerability of boys compared to girls [17,18,21]. Others
have previously shown the relative decline of heroin and the
growth of hallucinogens and stimulants [19,20]. Several studies
provide a picture of adolescent drug use [17,18,22,23] but no
representative study has been conducted in Italy. In addition,
compared to the available studies this has the largest sample and
longest follow-up [24].
Study limitations
In our study, each of the indicators used for drug use, drug
availability, and cost has several limitations.
The survey approach with self-administered paper and pencil
questionnaire is costly, time-consuming and requires cooperation
from school officials. As in all similar surveys, percentages must be
interpreted with caution as these are self-reported values. Survey
measurements of such highly sensitive or stigmatized behaviors
may generate inaccurate reporting and bias in survey estimates. A
discussion of potential biases in self-reporting of substance use is
provided elsewhere [11,25,26]. School-based surveys provide
prevalence estimates of substance use, but do not capture street
and homeless youths and other high-risk adolescents not found in
the school environment [27]. School attendance is irregular or
absent, and this subgroup is at a higher risk of illegal drug
involvement [1,22,28,29].
We use the term ‘‘perceived availability’’ when discussing
availability because it is the person’s perception that is being
measured [23]. We recognize that availability is multidimensional,
and respondents may consider a variety of factors in their answers,
including knowing where to get access, difficulty getting to an
access place, and possibly even monetary cost. However, we
suspect that for most respondents, what we are measuring is
perceived access, with little or no consideration of monetary cost.
While no systematic effort has been made to directly assess the
validity of these measures (since such an assessment would involve
actual attempts to obtain drugs), it must be said that the measures
do have a fairly high level of face validity, particularly since it is the
subjective reality of perceived availability being measured. It also
seems reasonable to assume that to a considerable extent,
perceived availability tracks actual availability. In addition,
differences in reported availability across drugs, which generally
correspond to reported prevalence of use, provide further evidence
of validity.
To place the data within a wider economic context, in the
results we also included rough data of drug prices, supplied by the
Interior Ministry. Over the years, in Italy there has been a strong
and substantial decrease in illegal drug prices at street level. Data
supplied by the Interior Ministry show that between 2001 and
2009, the minimum prices for cocaine, heroin (both white and
brown sugar), MDMA and LSD have decreased by over 30%. A
50% reduction was observed for LSD, from about 27 J/dose to
just over 14 J/dose. Cocaine cost dropped from around J 90/g
to about 59 J/g, white heroin from 78.5 J/g to about 53 J/g,
MDMA from about 22 J/tablet to about 15 J/tablet. The price
of marijuana and hashish remained stable during the observation
period, just below 9 J/g for both [6]. Although large regional
variations in true price can occur, there is little doubt that these
economic indicators should be taken into account when
considering trends in use.
Conclusions
Drug use is widespread among high-school students in Italy,
with cannabis being the most and heroin the least prevalent. Girls
are less vulnerable than boys to illegal drug use. In recent years, a
decrease in heroin use is overbalanced by a marked rise in
hallucinogen and stimulant use. Despite the fairly large number of
legislative and social communication initiatives for the prevention
of substance abuse in our country, the situation has not yet
improved to any significant degree.
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